Calendar

Calendar Articles

24/7 Wall St. has put together a preview of Cisco Systems, Wal-Mart and some of the other major companies reporting their quarterly results this week.
FDA rulings can make or break some companies. 24/7 Wall St. has collected eight key FDA decisions coming up in 2016 or 2017.
Shares of Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) surged early on Monday morning. This company is under the spotlight by the U.S. Food and Drug Administration’s Psychopharmacologic Drugs...
24/7 Wall St. has collected a few more U.S. Food and Drug Administration (FDA) decisions coming up in March.
24/7 Wall St. has collected three big FDA decisions coming up in March and added some color, along with the trading range and price target.
Earnings season for the fourth quarter of last year has now moved into February, and 24/7 Wall St. has put together a preview of six companies that are reporting their quarterly results this week.
24/7 Wall Street has put together a list of the top games we are looking forward to playing in 2016.
Pharmaceutical companies generally are involved in the lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk to a great amount of risk...
24/7 Wall St. again has put together a preview of some of the major companies reporting their quarterly results this week.
Oppenheimer sees Apple shars as unfairly undervalued on exaggerated fears over long-term iPhone shipment trends and lack of "something new."
24/7 Wall St. has collected several big FDA decisions coming up on the calendar for the month of October and added some color.
Friday's unemployment reading will be one of the last big-data economic reports that the Federal Open Market Committee has before its two-day meeting starting September 16 to decide whether to raise...
ThinkstockPharmaceutical and Biotech investors are about to get a real show for earnings this week. Big Pharma will bring earnings from Dow Jones Industrial Average companies Merck & Co. Inc....
Falling aluminum prices over the past year have absolutely demolished Alcoa stock. There is no doubt that Alcoa is in desperate need of a turnaround.
24/7 Wall St. has collected several big FDA decisions coming up on the calendar for the month of July and added some color.